Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Drug Payment Experiments Coming To Medicare, Medicaid

Executive Summary

Centers For Medicare and Medicaid Services releases 'request for information' on how to approach development of new payment models for prescription drugs in government-sponsored insurance.


Related Content

CMS Efforts On Value-Based Payments Should Focus On Removing Barriers, PhRMA Says
HHS Nominee Azar: Great News For Industry But ACA Reform Will Be Priority
CAR-T Indication-Based Pricing May Be Evaluated In Medicare Demo
HHS Leadership Upheaval Could Delay Initiatives Impacting Biopharma
Medicare Coding Change For Biosimilars Could Save $65bn, Firms Say
Novartis Begins CAR-T Payment Experiments With Outcomes-Based Contract With CMS
Policy People In The News: Patrick Conway Departs CMS
CMS Cancels Part B Demo Before HHS Secretary-Designate Price Does
Drug Use May Shift Under US Medicare Oncology Care Model; Here’s How


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts